Regulation, Digitization Mulled As Swiss Medtechs Look To An ‘EU+’ Vision For The Future
Swiss Parliament addresses proposal to allow US FDA-approved products onto the market
With Switzerland now operating as a third country to the EU, Swiss-based medtech manufacturers are keen to maximize their inherent advantages and build a basis for future growth.
